Am J Transplant, Volume 19, Suppl 3 Archives - Page 17 of 214 - ATC Abstracts

2019 American Transplant Congress
Renal Failure as a Complication of Vascularized Composite Allotransplantation
R. N. Barth¹, J. T. Shores², G. Brandacher², M. H. Levine³, A. Weissenbacher⁴, A. J. Nam¹, N. Shockcor¹, E. D. Rodriguez⁵, S. Schneeberger⁴, W. Lee², S. T. Bartlett¹, L. Levin³
¹University of Maryland School of Medicine, Baltimore, MD, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³University of Pennsylvania School of Medicine, Philadelphia, PA, ⁴Medical University Innsbruck, Innsbruck, Austria, ⁵New York University School of Medicine, New York, NY
*Purpose: Vascularized composite allotransplantation (VCA) has demonstrated impressive outcomes in areas of extremity (UETx), face (FTx), genitourinary, and abdominal wall transplantation with up to twenty…
2019 American Transplant Congress
Long Term Outcomes Using Tocilizumab For The Treatment Of Chronic Antibody Mediated Rejection
J. Choi¹, E. Huang¹, O. Aubert², A. Vo¹, A. Peng¹, R. Najjar¹, S. Sethi¹, N. Ammerman¹, K. Lim¹, D. Puliyanda¹, A. Loupy², S. Jordan¹
¹Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, ²Paris Translational Center for Organ Transplantation, Paris, France
*Purpose: Limited options exist for the treatment of kidney allograft rejection and preservation of allograft function. We reported our experience with anti-IL-6R (tocilizumab, TCZ) as…
2019 American Transplant Congress
Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients
E. M. Bugeaud, N. Bzowej, J. Hand, J. Scheuermann, H. Bohorquez, C. Brown, D. Bruce, I. Carmody, A. Cohen, S. Joshi, N. Latt, J. Seal, D. Sonnier, G. Therapondos, G. Tyson, N. Girgrah, G. Loss
Ochsner Health System, New Orleans, LA
*Purpose: With direct-acting antiviral (DAA) therapy, we feel that HCV+ organs are safe for all patients regardless of their HCV status and have adopted a…
2019 American Transplant Congress
Changes in the Fate of KDPI < 35% Kidneys before and after Implementation of the New Kidney Allocation System
K. Eng, E. Grodstein, L. Castellanos Reyes, L. Teperman, C. Sethna, P. Singer
Northwell Health, Manhasset, NY
*Purpose: Though the chances of long term graft survival are highest with low KDPI kidneys, there is concern that after implementation of the new kidney…
2019 American Transplant Congress
Allogenic Islets Cure Diabetes Following Transplantation in Omental Pouch in a Non-Human Primate Model
J. Lei¹, H. Deng¹, K. Lee¹, C. Peters¹, G. Rickert¹, R. Ivy¹, M. Coronel², E. Yolcu³, H. Shirwan⁴, A. García⁵, J. Markmann¹
¹Surgery, Massachusetts General Hospital, Boston, MA, ²Surgery, Georgia Institute of Technology, Atlanta, GA, ³Institute for Cellular Therapeutics, University of Louisville School of Medicine, louisville, KY, ⁴Department of Microbiology and Immunology, University of Louisville School of Medicine, louisville, KY, ⁵School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA
*Purpose: In the current standard clinical transplant approach, islet cells are administered intravenously into the portal system where they lodge in the liver. This approach…
2019 American Transplant Congress
Transplanting Thoracic Organs From Hcv Donors To Uninfected Patients: Evaluation Of Lung Allografts
Y. Lo¹, R. F. Padera¹, H. R. Mallidi², H. J. Goldberg³, S. K. Singh², A. Coppolino, III⁴, L. R. Baden⁵, A. E. Woolley⁵
¹Pathology, Brigham and Womens Hospital, Boston, MA, ²Cardiac and Thoracic Surgery, Brigham and Womens Hospital, Boston, MA, ³Pulmonary, Brigham and Womens Hospital, Boston, MA, ⁴Thoracic Surgery, Brigham and Womens Hospital, Boston, MA, ⁵Infectious Diseases, Brigham and Womens Hospital, Boston, MA
*Purpose: Prior to the development of direct acting antiviral (DAA) therapy for hepatitis C virus (HCV), there was concern that patients who received lungs from…
2019 American Transplant Congress
Pancreas Transplant Alone Using Donation After Cardiac Death Donors Has Similar Outcomes As Donation After Brain Death Donors
K. Espinoza¹, D. Wall¹, K. L. Lentine², J. R. Wellen¹, D. Hammad¹, D. C. Brennan³, T. Alhamad¹
¹Washinton University in St. Louis, St. Louis, MO, ²Saint Louis University, St. Louis, MO, ³Johns Hopkins University, St. Louis, MO
*Purpose: While outcomes of pancreas transplants are improving, there is a persistent hesitancy to use pancreas organs procured in the context of donation after cardiac…
2019 American Transplant Congress
Kidney Transplants Outcomes from Deceased Donors with Acute Kidney Injury
C. Jung¹, P. Sood², R. Mehta², D. Jorgensen², M. Molinari², S. Hariharan², A. Ganoza², D. Van Der Windt², M. Wijkstrom², C. Puttarajappa², A. Tevar³
¹Korea Univ. Anam Hospital, Seoul, Korea, Republic of, ²Univ. Pittsburgh Medical Center, Pittsburgh, PA, ³Department of Surgery, Univ. Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Due to the shortage of organs for transplantation, kidney transplants (KT) from marginal donors including donors with acute kidney injury (AKI) are expanding. Although…
2019 American Transplant Congress
Post-Liver Transplant Atrial Fibrillation is Associated with Markedly Reduced Short- and Long-Term Patient Survival
R. Rachwan¹, I. Kutkut¹, T. J. Hathaway², L. R. Timsina², M. S. Ghabril³, M. A. Lacerda³, C. A. Kubal², P. D. Bourdillon⁴, R. S. Mangus²
¹Medicine, Indiana University School of Medicine, Indianapolis, IN, ²Surgery, Indiana University School of Medicine, Indianapolis, IN, ³Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, IN, ⁴Cardiology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Postoperative atrial fibrillation (POAF) is the most common perioperative cardiac arrhythmia. Data regarding POAF following liver transplant (LT) is scarce. In the immediate post-LT…
2019 American Transplant Congress
Changes in Kidney Function Following Live Donor Nephrectomy
N. N. Lam¹, A. Lloyd¹, K. L. Lentine², R. R. Quinn³, B. R. Hemmelgarn³, S. Klarenbach¹, A. X. Garg⁴
¹University of Alberta, Edmonton, AB, Canada, ²Saint Louis University, St. Louis, LA, ³University of Calgary, Calgary, AB, Canada, ⁴Western University, London, ON, Canada
*Purpose: Understanding the decline in kidney function after live donor nephrectomy can inform the counselling and selection of donor candidates and guide the follow-up care…